Joint Formulary & PAD

Tinzaparin sodium - VTE treatment in pregnancy

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Subcutaneous injection (sc)
Associated Icons :
BNF SPC
Un
Restrictions / Comments :
Important
Off-label use.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Tinzaparin sodium
Indication :
VTE treatment in pregnancy
Group Name :
Keywords :
LMWH, low molecular weight heparins, venous thromboembolism
Brand Names Include :
Innohep
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Tinzaparin sodium is used to treat.

Other Drugs

Below are listed other drugs that are used to treat VTE treatment in pregnancy.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.